GENERATION AND APPLICATION OF A MONOCLONAL-ANTIBODY RAISED AGAINST A RECOMBINANT CYTOMEGALOVIRUS-SPECIFIC POLYPEPTIDE

被引:23
作者
JAHN, G
HARTHUS, HP
BROKER, M
BORISCH, B
PLATZER, B
PLACHTER, B
机构
[1] BEHRINGWERKE AG, W-3550 MARBURG, GERMANY
[2] UNIV BERN, INST PATHOL, CH-3000 BERN, SWITZERLAND
来源
KLINISCHE WOCHENSCHRIFT | 1990年 / 68卷 / 20期
关键词
Cytomegalovirus; Immunofluorescence; Immunohistochemistry; Monoclonal antibody; Phosphorylated protein pp150; Procaryotic expression; Recombinant antigen;
D O I
10.1007/BF01646545
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Procedures for diagnostics of cytomegalovirus infections include histopathology, cell culture, serology, and direct detection of viral antigens or nucleic acids within infected cells or tissues. In order to develop a new diagnostic reagent for viral antigen detection, we generated a mouse monoclonal antibody. This antibody was raised against a recombinant antigen representing part of the large phosphorylated structural protein pp150 of human cytomegalovirus. The monoclonal antibody was shown to be useful for antigen detection by immunofluorescence and immunoenzymatic staining in infected cells from cell culture as well as from infected organs. The antibody proved to be reactive even in paraffin-embedded sections from tissue specimens. © 1990 Springer-Verlag.
引用
收藏
页码:1003 / 1007
页数:5
相关论文
共 21 条
[1]  
BORISCH B, 1988, VIRCHOWS ARCH B, V55, P93
[2]   DEFINED MONOCLONAL-ANTIBODIES TO ESCHERICHIA-COLI BETA-GALACTOSIDASE AS A TOOL FOR CHARACTERIZATION OF RECOMBINANT EXPRESSION PRODUCTS [J].
BROKER, M ;
HARTHUS, HP .
FEBS LETTERS, 1989, 257 (01) :118-122
[3]   VECTORS FOR REGULATED HIGH-LEVEL EXPRESSION OF PROTEINS FUSED TO TRUNCATED FORMS OF ESCHERICHIA-COLI BETA-GALACTOSIDASE [J].
BROKER, M .
GENE ANALYSIS TECHNIQUES, 1986, 3 (03) :53-57
[4]  
CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125
[5]   RAPID DETECTION AND QUANTITATION OF HUMAN CYTOMEGALOVIRUS IN URINE THROUGH DNA HYBRIDIZATION [J].
CHOU, S ;
MERIGAN, TC .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (16) :921-925
[6]  
EMANUEL D, 1987, TRANSPLANT P, V19, P132
[7]   GANCICLOVIR TREATMENT OF CYTOMEGALOVIRUS DISEASE IN TRANSPLANT RECIPIENTS AND OTHER IMMUNOCOMPROMISED HOSTS [J].
ERICE, A ;
JORDAN, C ;
CHACE, BA ;
FLETCHER, C ;
CHINNOCK, BJ ;
BALFOUR, HH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (22) :3082-3087
[8]  
JAHN G, 1990, CURR TOP MICROBIOL, V154, P171
[9]   THE 2 MAJOR STRUCTURAL PHOSPHOPROTEINS (PP65 AND PP150) OF HUMAN CYTOMEGALOVIRUS AND THEIR ANTIGENIC PROPERTIES [J].
JAHN, G ;
SCHOLL, BC ;
TRAUPE, B ;
FLECKENSTEIN, B .
JOURNAL OF GENERAL VIROLOGY, 1987, 68 :1327-1337
[10]   MAP POSITION AND NUCLEOTIDE-SEQUENCE OF THE GENE FOR THE LARGE STRUCTURAL PHOSPHOPROTEIN OF HUMAN CYTOMEGALOVIRUS [J].
JAHN, G ;
KOUZARIDES, T ;
MACH, M ;
SCHOLL, BC ;
PLACHTER, B ;
TRAUPE, B ;
PREDDIE, E ;
SATCHWELL, SC ;
FLECKENSTEIN, B ;
BARRELL, BG .
JOURNAL OF VIROLOGY, 1987, 61 (05) :1358-1367